Building on the 2017 demonstration that Cassiopea meets behavioral sleep criteria (reversible nocturnal quiescence, elevated arousal threshold, daytime rebound after deprivation) , this preprint asks whether sleep regulation is also conserved. The team first validated a pulse-rate sleep/wake threshold via drop-tests, then performed RNAseq on rhopalia (the radial ganglia harboring pacemakers) after light-based sleep deprivation (LSD) and mechanical sleep deprivation (MSD). Chrna-Ξ±-E emerged as the top differentially expressed gene in ComBat-Seq merged datasets (24 consistently DE genes) .
Four converging lines support causality: (1) tubocurarine (nAChR antagonist) increased and nicotine decreased ganglionic inter-spike intervals dose-dependently (e.g., 600 Β΅M DTC p=4.0e-9; 75 Β΅M nicotine p=1.3e-8); (2) in situ hybridization localizes chrnal-E to the oral ganglia, with expression area expanding after LSD (p=1.1e-9, control n=252 ganglia, SD n=353); (3) novel Cassiopea RNAi feeding produced knockdown and increased daytime sleep (p=3.3e-6 for expression reduction); (4) field qPCR at Key Largo showed chrnal-E lowest at ZT19 in controls but peaking there after 7h LSD (p=.0013) β expression tracks wake drive, mirroring Drosophila Redeye .
Strengths: two independent deprivation modalities, batch-correction across rounds, behavioral plus electrophysiological plus spatial-expression plus functional (RNAi) triangulation, and field circadian sampling β a rarely rigorous design for an early-branching metazoan. The species foundation was previously well characterized, including the sleep phenotype and melatonin/pyrilamine responsiveness .
Limitations: MSD had only n=3 animals and no nighttime recording assessment β the smallest arm carries the merged-dataset conclusion. One LSD animal consistently clustered with controls (noted by authors), and RNAi knockdown at ZT11 in LSD animals was non-significant, so the wake-promotion model is partly inferential. No rescue experiment (RNAi + chrnal-E overexpression) establishes specificity; mcol is an acceptable negative control but a second sleep-gene knockdown would strengthen causal attribution. AlphaFold structural homology to human Chrna7 (charged vestibule residues) is suggestive, not functional proof. Species ambiguity is under-addressed: Florida Keys Cassiopea include C. andromeda mitotypes and lab stocks may be mixed , and mitochondrial identity does not even predict nuclear ancestry . The prior sleep paper itself genotyped multiple COI haplotypes among Florida specimens , so chrnal-E findings should be validated in a genetically characterized clonal line.
What would change the conclusion: CRISPR knockout or rescue showing chrnal-E is necessary and sufficient; single-cell RNAseq resolving whether the receptor is neuronal vs. non-neural (given non-nuclear, cytosolic mRNA localization reported); and dose-response rescue of the RNAi sleep phenotype. Confidence in the wake-promotion claim: moderate-to-strong; in the evolutionary "conserved cholinergic homeostat" framing: plausible but rests on one gene in one cnidarian lineage where Chrns independently radiated .
Author-specific reviews:
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.